Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Cahn

Showing results (81-90 of 207) with videos related to

Pageof 21
Sort By:
Plos One|October 25, 2012
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeuticsFranco Lori, Davide De Forni, Elly Katabira, et al.
Actualizaciones En SIDA E Infectologia|February 16, 2016
[Barriers to adherence and retention in public and private healthcare according to patients and health workers]Inés Arístegui, Analía Dorigo, Lina Bofill, et al.
Trials|July 26, 2018
Physician-delivered motivational interviewing to improve adherence and retention in care among challenging HIV-infected patients in Argentina (COPA2): study protocol for a cluster randomized controlled trialOmar Sued, Isabel Cassetti, Diego Cecchini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Comparable pharmacokinetics of generic indinavir (Inhibisam) versus brand indinavir (Crixivan) when boosted with ritonavirCarlos Zala, Christopher S Alexander, Claudia Ochoa, et al.
Plos One|March 21, 2012
Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive personsMaria Florencia Quiroga, Matias Tomas Angerami, Natalia Santucci, et al.
AIDS Care|April 3, 2018
Suicidality among nonadherent patients living with HIV in Buenos Aires, Argentina: prevalence and correlatesVioleta J Rodriguez, Omar Sued, Diego Cecchini, et al.
Journal of the International AIDS Society|September 27, 2012
Preferred antiretroviral drugs for the next decade of scale upIsabelle Andrieux-Meyer, Alexandra Calmy, Pedro Cahn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2009
A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patientsMarianne Harris, Hélène Côté, Claudia Ochoa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2021
Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT TrialPrincy Kumar, Margaret Johnson, Jean-Michel Molina, et al.
AIDS Care|October 22, 2013
Patient-provider perceptions on engagement in HIV care in ArgentinaLina Margarita Bofill, Maria Lopez, Analia Dorigo, et al.
Pageof 21

Showing results (81-90 of 207) with videos related to

Sort By:
Pageof 21
Plos One|October 25, 2012
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeuticsFranco Lori, Davide De Forni, Elly Katabira, et al.
Actualizaciones En SIDA E Infectologia|February 16, 2016
[Barriers to adherence and retention in public and private healthcare according to patients and health workers]Inés Arístegui, Analía Dorigo, Lina Bofill, et al.
Trials|July 26, 2018
Physician-delivered motivational interviewing to improve adherence and retention in care among challenging HIV-infected patients in Argentina (COPA2): study protocol for a cluster randomized controlled trialOmar Sued, Isabel Cassetti, Diego Cecchini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Comparable pharmacokinetics of generic indinavir (Inhibisam) versus brand indinavir (Crixivan) when boosted with ritonavirCarlos Zala, Christopher S Alexander, Claudia Ochoa, et al.
Plos One|March 21, 2012
Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive personsMaria Florencia Quiroga, Matias Tomas Angerami, Natalia Santucci, et al.
AIDS Care|April 3, 2018
Suicidality among nonadherent patients living with HIV in Buenos Aires, Argentina: prevalence and correlatesVioleta J Rodriguez, Omar Sued, Diego Cecchini, et al.
Journal of the International AIDS Society|September 27, 2012
Preferred antiretroviral drugs for the next decade of scale upIsabelle Andrieux-Meyer, Alexandra Calmy, Pedro Cahn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2009
A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patientsMarianne Harris, Hélène Côté, Claudia Ochoa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2021
Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT TrialPrincy Kumar, Margaret Johnson, Jean-Michel Molina, et al.
AIDS Care|October 22, 2013
Patient-provider perceptions on engagement in HIV care in ArgentinaLina Margarita Bofill, Maria Lopez, Analia Dorigo, et al.
Pageof 21